Nycomed commences bank syndication process

20.10.2006

Nycomed today commences the syndication of its new € 5.7 billion senior credit facilities, the proceeds of which will be used to finance its previously announced acquisition of ALTANA Pharma and to refinance existing debt.

Nycomed currently intends to launch tender offers later this year for all of the 11.75% Senior PIK Notes due 2013 and the 11.50% Senior Notes due 2013. The tender offers are expected to be conditional upon, among other things, completion of the ALTANA Pharma acquisition and the related financing.


About Nycomed

Nycomed is a pharmaceutical company dedicated to meeting needs in Europe. The company provides hospital products throughout the region and general practitioner and pharmacy medicines in selected markets.

New products are sourced through licensing agreements with research companies. Here Nycomed provides late-stage clinical development, registration and marketing.

Headquartered in Roskilde, Denmark, the company employs about 3,500 people throughout Europe and Russia-CIS. Nycomed is privately owned and had a 2005 revenue of € 747.5 million.

For more information visit www.nycomed.com

 

For further information

Runar Bjørklund, CFO
Phone: +45 46 77 11 11
Mobile: +45 22 41 12 27

Christian Seidelin, VP Corporate Finance
Phone: +45 46 77 11 11
Mobile: +45 20 40 70 72

 

For further information

Media:
General phone:

+41 44 555 15 10
Beatrix Benz,

phone: +41 44 555 1508
Tobias Cottmann,

phone: +41 44 555 1501

Investors:
Christian B. Seidelin,

phone: +41 44 555 11 04

Related information


English PDF
Danish PDF

Top of page

Takeda Pharma